ConductScience.org, home

Paper39403308

Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy.

Bugianesi E and 7 others. Pragmat Obs Res, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy. Papers, record 39403308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39403308

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy.
PubMed
Journal
Pragmat Obs Res
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.16, provisional
iCite
Revised in PubMed
2024-10-16
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bugianesi EElisabetta
2Miele LLuca
3Donnarumma GGiovanna
4Grau KKatrine
5Mancuso MMariarosaria
6Prasad PPreethy
7Leith AAndrea
8Higgins VVictoriahttps://orcid.org/0000-0002-3901-7390

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132598051Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.Aliment Pharmacol Ther2020https://conductscience.org/library/papers/32598051PubMed
231341444Non-Alcoholic Fatty Liver Disease, an Overview.Integr Med (Encinitas)2019https://conductscience.org/library/papers/31341444PubMed
33280274Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques.Dig Dis Sci1988https://conductscience.org/library/papers/3280274PubMed
412879405Statin therapy for the treatment of diabetic dyslipidemia.Diabetes Metab Res Rev2003https://conductscience.org/library/papers/12879405PubMed
518826746Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand.Curr Med Res Opin2008https://conductscience.org/library/papers/18826746PubMed
630875495Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes.Atherosclerosis2019https://conductscience.org/library/papers/30875495PubMed
730547371Understanding Patient Preferences and Unmet Needs in Non-alcoholic Steatohepatitis (NASH): Insights from a Qualitative Online Bulletin Board Study.Adv Ther2019https://conductscience.org/library/papers/30547371PubMed
825873207
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
Aliment Pharmacol Ther2015https://conductscience.org/library/papers/25873207PubMed
911296698Imaging of hepatic steatosis.Semin Liver Dis2001https://conductscience.org/library/papers/11296698PubMed
1029886156Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.J Hepatol2018https://conductscience.org/library/papers/29886156PubMed
1134133035Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysis.Br J Clin Pharmacol2022https://conductscience.org/library/papers/34133035PubMed
1225312733Adverse effects of statins - myths and reality.Curr Pharm Des2015https://conductscience.org/library/papers/25312733PubMed
1336626630The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.Hepatology2023https://conductscience.org/library/papers/36626630PubMed
1424374462Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/24374462PubMed
1527843332Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015.Diabetes Metab Syndr Obes2016https://conductscience.org/library/papers/27843332PubMed
1636675217GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives.Int J Mol Sci2023https://conductscience.org/library/papers/36675217PubMed
1730924946Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.Hepatology2019https://conductscience.org/library/papers/30924946PubMed
1830839334Implementation of Clinical Practice Guidelines in the Health Care Setting: A Concept Analysis.ANS Adv Nurs Sci2019https://conductscience.org/library/papers/30839334PubMed
1934588764Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease.Drug Des Devel Ther2021https://conductscience.org/library/papers/34588764PubMed
2030819364Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.J Am Coll Cardiol2019https://conductscience.org/library/papers/30819364PubMed

See all 47 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39403308

GET https://conductscience.org/api/papers/v1/39403308/references?page=2